Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
If no treatment for Parkinson’s disease, an upcoming experience offers hope More than 10 million people Lives with a disorder that a progress can be on the horizon.
Researchers, led by Scientists from the University of Cambridge, plan to prepare a new kind of brain implant to treat Parkinson’s disease from small groups of brain cells. This approach is detailed in a university statement From January 23, the aggressive disease will be repaired and tested in animals first.
“Our latest goal is to create an accurate brain therapy that can restore normal brain functions in people with Parkinson,” Cambridge researcher George Malliaras, who will go from Cambridge University, which is jointly leading the project.
Parkinson’s disease In the brain, a progressive neurodehenerative disorder arising from the death and death of neurons, especially dopamine. Reduced dopamine levels violate normal brain activity that affects motor control and causes movement problems. Scientists do not know what the disease is triggered and there is no cure. Dopamine-based medications are effective at the beginning of treatment, although often causes significant and unpleasant side effects over time.
Scientists have been Looking for a treat for Parkinson’s disease that is more than a century. Researchers conduct research Cell replacement therapy As a potential treatment that replaces dead dopamine cells with new ones. These current approaches could not fully unite transplanted cells with the nervous system of the brain.
Malliaras and Barker team hope to solve this problem by developing a transplant from small groups of Midbrain Organoids-small brain cells. Similar to cell exchange therapy, researchers plan to transfer these Midbrain’s organoids to the brain. Then, “Advanced materials and electric stimulation” to support the transplanted cell nervous system and the restoration of lost nerve roads.
“To date, there is a little serious investment in the interface, which has a human brain, an interface, which is outside the ‘brutal force’ or high invasive implants,” he said. Aria is an English Research and Development Agency that funds the implant project of Parkinson. “We show that the most complex and destructive brain disorders are possible to develop, identify and treat delicate vehicles. As a result, it can be transformative to people with experiences of brain diseases.”
After the project is officially launched, the team is seen to develop the implant. Hopefully, in a few years – or maybe months – we will report on the success of the first animal tests.
